Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation save search
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
MURA | $3.595 -1.78% -1.81% 110K
|
| Email alert
Add to watchlist
presentation meeting
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
BCAB | $2.35 4.91% 4.68% 390K
|
| Email alert
Add to watchlist
presentation meeting
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
IOBT | $1.455 -1.02% -1.03% 57K
|
| Email alert
Add to watchlist
biotech presentation for meeting
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K
|
Health Technology
| Email alert
Add to watchlist
presentation asco pharmaceuticals for meeting
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K
|
Health Technology
| Email alert
Add to watchlist
presentation for meeting
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
SWTX | $43.37 -1.43% -1.45% 470K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
presentation for meeting therapeutics
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
BTAI | News | $2.7 -9.09% -10.0% 880K
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -8.75%
bxcl701 keytruda presentation asco pancreatic for meeting trial therapeutics
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
| Email alert
Add to watchlist
MDNAF | $1.14 -17.54% 58K
|
n/a
| Email alert
Add to watchlist
mdna11 presentation asco meeting study
Immunocore announces upcoming presentation and posters at ASCO 2024
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
IMCR | $58.52 2.11% 2.07% 390K
|
Manufacturing
|
| O: -0.1%
H: 2.34%
C: 2.13%
presentation asco
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
Published: 2024-04-24 (Crawled : 14:00) - prnewswire.com
IDYA | News | $39.85 2.13% 2.08% 1.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
melanoma presentation asco for study
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
ALXO M | $16.24 4.77% 4.56% 440K
|
Commercial Services
|
| O: 0.58%
H: 4.23%
C: 4.04%
presentation asco for meeting
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
MRUS | $41.96 2.79% 2.72% 740K
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
presentation asco for meeting
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 0.46%
H: 0.91%
C: -7.76%
presentation meeting
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
HOWL | $6.405 -0.54% -0.55% 82K
|
Professional, Scientific, and T...
|
| O: -0.93%
H: 4.23%
C: 0.16%
wtx-124 presentation for meeting therapeutics
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
INAB | $1.03 -0.96% -0.97% 150K
|
|
| O: 5.18%
H: 0.0%
C: 0.0%
presentation cell meeting therapy
Whitestone REIT Publishes Investor Presentation Highlighting Execution of Our Strategy to Continue Driving Long Term Sustainable Value Creation
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
WSR | $11.38 -1.04% 0.0% 150K
|
Finance
|
| O: -0.35%
H: 0.0%
C: 0.0%
presentation
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
TNXP | $0.1587 1.21% 1.2% 950K
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
presentation pharmaceuticals microcap
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
Published: 2024-04-24 (Crawled : 11:00) - globenewswire.com
ASLN | News | $0.4863 3.69% 3.56% 1M
|
Health Technology
|
| O: -2.55%
H: 6.38%
C: 0.0%
conference presentation international pharmaceuticals for copd
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $1.87 -10.95% -12.3% 1.4M
|
Health Technology
|
| O: 2.56%
H: 2.0%
C: 0.0%
adi-270 presentation cell preclinical for meeting therapy
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
SPRB | News | $0.705 0.54% 0.54% 420K
|
Health Technology
|
| O: -2.86%
H: 2.94%
C: 1.47%
presentation endocrine meeting
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.